Canada’s Newborn Screening Patchwork, and Why Researchers Are Still Pushing for a Global Standard

A single blood test at birth can mean the difference between a child with sickle cell disease starting preventive antibiotics in their first weeks of life, or going undiagnosed until a medical crisis forces the question. That’s the premise behind newborn screening, and a review published in the International Journal of Neonatal Screening earlier this year lays out just how unevenly it’s applied around the world — Canada included.

The review, co-authored by researchers at Cincinnati Children’s Hospital Medical Center, notes that high-resource regions including the United States, parts of Europe, the UK, and Canada have adopted newborn screening for sickle cell disease using a range of different strategies. That word — different — is doing a lot of work. Unlike the U.S., where screening became universal across all fifty states by 2006, Canada has no single national standard. Screening is decided provincially, which means a baby’s odds of being screened at birth can depend more on postal code than on medical need.

Most Canadian provinces and territories now include sickle cell disease in their newborn screening panels, a genuine improvement over where things stood a decade ago. But gaps remain, and organizations like the Sickle Cell Disease Association of Canada continue to push for the remaining provinces and territories to close theirs, arguing that a child’s access to early, potentially life-saving care shouldn’t depend on where in the country they happen to be born.

The stakes are highest for the most severe complications: undiagnosed sickle cell disease in infancy carries real risk of serious infection and, in some cases, stroke — both of which are far more preventable when a diagnosis comes at birth rather than after a crisis. Globally, screening pilot programs are also expanding in lower-resource settings across Africa, Brazil, and India, where the majority of the world’s sickle cell disease cases occur but where comprehensive newborn screening has historically been hardest to reach.